| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AKRO | Common Stock | Options Exercise | $140,180 | +20,000 | +452% | $7.01* | 24,429 | 13 Oct 2022 | Direct | F1 |
| transaction | AKRO | Common Stock | Sale | $796,400 | -20,000 | -82% | $39.82 | 4,429 | 13 Oct 2022 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AKRO | Stock Option (Right to Buy) | Options Exercise | $0 | -20,000 | -7.1% | $0.000000 | 261,829 | 13 Oct 2022 | Common Stock | 20,000 | $7.01 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | The reported transaction was effected pursuant to a Rule 10b5-1 trading plan dated June 2, 2021, previously adopted by the Reporting Person. |
| F2 | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $39.75 to $40.03, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. |
| F3 | 25% of this option vested on April 1, 2020, and the remaining 75% of this option shall vest in 36 equal monthly installments thereafter. |